Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348972 · ClinicalTrials.gov registry record · Phase 1
Lantus in Prediabetes
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00348972 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 20 participants.
The verdict
NCT00348972, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To assess the safety, tolerability, and efficacy of Lantus® (insulin glargine) in prediabetes (IFG or IGT).
Interventions
- DRUG Lantus® (insulin glargine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348972
The ClinicalTrials.gov registry entry for NCT00348972 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lantus® (insulin glargine) is the first listed.
NCT00348972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00348972 about?
NCT00348972 is a clinical study titled "Lantus in Prediabetes". To assess the safety, tolerability, and efficacy of Lantus® (insulin glargine) in prediabetes (IFG or IGT).
What is the current status of trial NCT00348972?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2002-02.
What interventions are being tested in trial NCT00348972?
The interventions under investigation include: Lantus® (insulin glargine) (DRUG).
Who is sponsoring clinical trial NCT00348972?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.